NovoCure (NVCR) BidaskScore is increased to Bought

NovoCure

The BidaskScore of NovoCure NVCRNVCR shows that the shares of the company are now NVCRStrongly Bought Bought by investors.

The BidaskScore of the Health Care EquipmentHealth Care Equipment shows that the sector is Health Care EquipmentStrongly Bought Held since October 4.

Here are the BidAskScore of other related companies in the Health Care Equipment sector:

Novocure Ltd. operates as a commercial-stage oncology companyˌ which offers devices for continuous home use by patients. It develops novottf-100Aˌ a portable non-invasive investigational device for cancer treatment using tumor treating fields. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helierˌ the United Kingdom.

NovoCure

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.